Nohla Therapeutics Initiates Global LAUNCH Phase 2 Trial of NLA101 in Patients with AML
February 13, 2018 13:00 ET | Nohla Therapeutics
SEATTLE, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a clinical stage biopharmaceutical company focused on the development of universal, off-the-shelf cell therapies to treat...
Nohla Therapeutics Granted Orphan Drug Designation in the European Union for NLA101 in the Treatment of Hematopoietic Stem Cell Transplantation
January 23, 2018 13:00 ET | Nohla Therapeutics
SEATTLE, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a clinical stage biopharmaceutical company focused on the development of universal donor, off-the-shelf cell therapies to...
Nohla Therapeutics Announces Hiring of Jim Johnson as Chief Financial Officer
January 04, 2018 16:00 ET | Nohla Therapeutics
SEATTLE, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading cell therapy company that provides a short-term bridge to long-term health for patients with critical diseases,...
Nohla Therapeutics Awarded $6.9 Million Grant from the California Institute of Regenerative Medicine to Further Develop NLA101 Cell Therapy for the Treatment of Patients with Acute Myeloid Leukemia
September 28, 2017 15:33 ET | Nohla Therapeutics
SEATTLE, Sept. 28, 2017 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading developer of universal donor cell therapies for patients with hematologic malignances and other critical...
Nohla Therapeutics President and CEO, Katie Fanning, to Present at 2017 Life Science Innovation Northwest Conference
May 16, 2017 05:30 ET | Nohla Therapeutics
SEATTLE, May 16, 2017 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading innovator in the development of off-the-shelf universal donor cellular therapies, announced today that Katie...
Nohla Therapeutics Announces Collaboration with University of California, Davis to Optimize Manufacturing Process and Supply Cell Therapy Product for Clinical Trials
March 28, 2017 05:30 ET | Nohla Therapeutics
SEATTLE, March 28, 2017 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading innovator in the development of off-the-shelf universal donor cellular therapies, announced today the...
Nohla Therapeutics to Present at the Cowen and Company 37th Annual Health Care Conference on March 7th, 2017
February 14, 2017 05:30 ET | Nohla Therapeutics
SEATTLE, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading innovator in the development of universal donor cellular therapies for the treatment of patients with blood...
Nohla Therapeutics Appoints Kathleen Fanning as President and Chief Executive Officer
February 02, 2017 05:30 ET | Nohla Therapeutics
SEATTLE, Feb. 02, 2017 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading developer of universal donor cellular therapies for the treatment of patients with life threatening...
Positive Pre-Clinical and Clinical Data for Nohla Therapeutics’ Cell Product to Be Presented at the 58th ASH Annual Meeting and Exposition
December 01, 2016 05:30 ET | Nohla Therapeutics
SEATTLE, Dec. 01, 2016 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading developer of universal donor cellular therapies for the treatment of patients with life threatening...
Nohla Therapeutics Appoints Shelly Heimfeld, Ph.D., Executive Vice President of Research and Manufacturing
November 30, 2016 05:30 ET | Nohla Therapeutics
SEATTLE, Nov. 30, 2016 (GLOBE NEWSWIRE) -- Nohla Therapeutics Inc. (Nohla), a leading developer of universal donor cellular therapies for the treatment of patients with life threatening...